Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future

Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future

Background: Hepatocellular carcinoma (HCC) still represents a human tumor entity with very limited therapeutic options, especially for advanced stages. Here, immune checkpoint modulating drugs alone or in combination with local ablative techniques could open a new and attractive therapeutic “door” t...

Full description

Bibliographic Details
Main Authors: Matthias Ocker, Christian Mayr, Tobias Kiesslich, Sebastian Stintzing, Daniel Neureiter
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
hepatocellular carcinoma
immunotherapy
immune checkpoint inhibitors
locoregional treatment
Online Access:https://www.mdpi.com/2072-6694/13/7/1558

Internet

https://www.mdpi.com/2072-6694/13/7/1558

Similar Items